Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole and Anidulafungin for Invasive Aspergillosis
NCT00620074Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Aug 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of anidulafungin in invasive aspergillosis (IA), sponsored by Pfizer. Started Aug 2008; status: terminated.
02
Drugs
anidulafungin
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT00620074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620074.